Immune Responses After Malaria Infection and Next Generation Malaria Vaccine
A special issue of Vaccines (ISSN 2076-393X). This special issue belongs to the section "Vaccines Against Tropical and Other Infectious Diseases".
Deadline for manuscript submissions: closed (31 January 2026) | Viewed by 985
Special Issue Editor
Special Issue Information
Dear Colleagues,
Malaria continues to pose a significant threat to global health. Current vaccines provide only suboptimal and waning protection, highlighting the urgent need for a deeper understanding of immunity following infection and immunization. Such fundamental knowledge is essential for the development of enhanced strategies that could eradicate malaria.
The success of mRNA vaccines in combating COVID-19 has provided novel insights into the development of vaccines against infectious diseases. The exploration of novel vaccine modalities, including mRNA technology, is crucial for addressing the persistent challenge of malaria. Additionally, the identification of new antigens that prevent transmission, targeting both the various stages of Plasmodium and its mosquito vector, should be prioritized as part of next-generation vaccine strategies.
To obtain a comprehensive understanding of the immune response to malaria and the latest advances in vaccine development, this Special Issue will focus on recent scientific progress and technological innovations in the field. We invite you to contribute original research, observations, or review articles that explore the following areas: 1) Immune responses during or after malaria infection; 2) Immune development and protection following vaccination; and 3) Advances in the development of vaccines, including antigen discovery and innovative delivery strategies.
We look forward to receiving your contributions, which will help shape the future of malaria vaccine research.
Dr. Yu-Min Chuang
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- humoral immune response
- cellular immune response
- malaria
- antimalaria vaccine
- Plasmodium
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
